Recurrent Urinary Tract Infections clinical trials

Explore recruiting recurrent urinary tract infections clinical trials.

Recruiting recurrent urinary tract infections studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Recurrent Urinary Tract Infections trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Fecal microbiota transfer for the secondary prevention of recurrent urinary tract infections in premenopausal women: a phase II trial (FEMITRANS)

Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

RETRAIN - Multicentre randomised double-blind superiority trial with a roll-over phase to evaluate the efficacy of OM-89 vs placebo in reducing antibiotic consumption associated with the treatment of urinary tract infections in patients with a neurological bladder.

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

Randomized, multicenter, open-label clinical trial to evaluate the clinical and microbiological impact of methenamine hippurate as an alternative prophylaxis to antibiotics in the management of recurrent urinary tract infections in women

Spain

Therapeutic use (Phase IV) EU CTIS Study details

Multicentre, randomised, double-blind, placebo-controlled clinical trial to confirm the efficacy, safety, and clinical impact of the mucosal bacterial therapeutic vaccine MV140 in women with non-complicated recurrent urinary tract infections (rUTIs).

Portugal

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Randomized, Double-Blind, Placebo-Controlled Clinical Trial Evaluating the Efficacy of Transfer Factor TFI Treatment by Assessing the Number of New Infections in Subjects with Recurrent Respiratory or Urinary Tract Infections or Recurrent Herpetic Infections Recorded over a Period of 6 Months from Randomization

Czechia

Therapeutic confirmatory (Phase III) EU CTIS Study details

Recurrent Urinary Tract Infections trials by city

Recurrent Urinary Tract Infections in Toronto Recurrent Urinary Tract Infections in Vancouver Recurrent Urinary Tract Infections in Montreal Recurrent Urinary Tract Infections in Calgary Recurrent Urinary Tract Infections in Edmonton Recurrent Urinary Tract Infections in Ottawa Recurrent Urinary Tract Infections in Winnipeg Recurrent Urinary Tract Infections in Quebec City Recurrent Urinary Tract Infections in Hamilton Recurrent Urinary Tract Infections in Kitchener Recurrent Urinary Tract Infections in London Recurrent Urinary Tract Infections in Halifax Recurrent Urinary Tract Infections in New York Recurrent Urinary Tract Infections in Los Angeles Recurrent Urinary Tract Infections in Chicago Recurrent Urinary Tract Infections in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease